Scarica l'app Stockscreener
393.19
0.11%
0.44
Dopo l'orario di chiusura:
393.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$392.75
Aprire:
$395.93
Volume 24 ore:
2.47M
Relative Volume:
1.28
Capitalizzazione di mercato:
$85.39B
Reddito:
$200.42B
Utile/perdita netta:
$5.24B
Rapporto P/E:
16.73
EPS:
23.5042
Flusso di cassa netto:
$6.45B
1 W Prestazione:
-0.38%
1M Prestazione:
+4.40%
6M Prestazione:
+16.24%
1 anno Prestazione:
+3.33%
Intervallo 1D:
$389.55
$396.52
Intervallo di 1 settimana:
$384.30
$396.52
Portata 52W:
$273.71
$408.00
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
393.19 | 85.29B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
380.31 | 347.39B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
90.98 | 118.62B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
277.40 | 75.21B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
305.42 | 37.06B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-08 | Iniziato | Evercore ISI | In-line |
| 2026-02-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Iniziato | Goldman | Neutral |
| 2025-07-21 | Downgrade | Argus | Buy → Hold |
| 2025-07-18 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health (ELV): One of the Best Undervalued Stocks to Buy According to the Financial Media - Yahoo Finance
What Does Elevance Health's Q1 2026 Performance Signal for Investors - Kavout
Elevance Health (ELV) Makes Progress on Medicare Advantage Compl - GuruFocus
Elevance Health (ELV) Progresses on Medicare Advantage Enrollmen - GuruFocus
Elevance avoids Medicare Advantage enrollment freeze, for now - Modern Healthcare
Elevance Health gains as Medicare sanctions risk abates (ELV) - Seeking Alpha
Elevance Health Avoids CMS Sanctions After Attesting to Corrective Steps - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Bullish Elevance Health Insiders Loaded Up On US$3.68m Of Stock - Yahoo Finance
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide - Business Wire
UBS Reaffirms Buy on Elevance Health (ELV) Amid Stronger Industry Trends - Insider Monkey
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health Price Target Raised to $480.00/Share From $408.00 by Barclays - Moomoo
Barclays Adjusts Elevance Health Price Target to $480 From $408, Maintains Overweight Rating - Moomoo
Elevance Health Stock Analysis: Guidance Raised to $27, Street High at $498, TIKR Target at $534 - TIKR.com
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Promising 1.5% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
What Elevance Health (ELV)'s Raised EPS Outlook and Insider Stock Sale Means For Shareholders - Yahoo Finance
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Elevance Health Price Target Raised to $460.00/Share From $400.00 by UBS - Moomoo
Elevance Health (ELV) Up 12.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Are Wall Street Analysts Predicting Elevance Stock Will Climb or Sink? - Yahoo Finance
UBS Adjusts Price Target on Elevance Health to $460 From $400, Maintains Buy Rating - marketscreener.com
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Elevance executive ordered to testify in Medicare Advantage fraud case - statnews.com
Analysts’ Top Healthcare Picks: Protara Therapeutics (TARA), Elevance Health (ELV) - The Globe and Mail
Defensive Market Strategies Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health CAO Ronald Penczek sells $617,192 of company stock - Investing.com
Elevance Health Insider Sold Shares Worth $617,192, According to a Recent SEC Filing - marketscreener.com
Elevance Health (NYSE: ELV) CAO exercises options, sells 1,531 shares - Stock Titan
Elevance Health Is Maintained at Outperform by Mizuho - Moomoo
Deutsche Bank Upgrades Elevance Health to Buy From Hold, Adjusts PT to $498 From $363 - Moomoo
Mizuho Adjusts Price Target on Elevance Health to $435 From $385, Maintains Outperform Rating - marketscreener.com
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
ELV (NYSE: ELV) Form 144 filed for 1,531 shares on 05/19/2026 - Stock Titan
How providers are responding to Elevance’s out-of-network policy - Modern Healthcare News
Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Stable Healthcare Giant with Strategic Growth Potential - DirectorsTalk Interviews
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care - Business Wire
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star | Britannica Money - Britannica
Bessemer Group Inc. Sells 4,178 Shares of Elevance Health, Inc. $ELV - MarketBeat
Greene County hospital serves Anthem with second breach notice over claim payments - Inside INdiana Business
Director at Elevance Health (ELV) receives 563 deferred stock units as board compensation - Stock Titan
Elevance Health (ELV) director Amy Schulman receives 563 deferred stock units - Stock Titan
Elevance Health (ELV) director receives 563 deferred stock units as board compensation - Stock Titan
Elevance Health (ELV) director Ramiro Peru receives 563 deferred stock units as board pay - Stock Titan
Board member gets 563 deferred stock units at Elevance Health (NYSE: ELV) - Stock Titan
Elevance Health (ELV) director Bahija Jallal awarded 563 deferred stock units - Stock Titan
Board member at Elevance Health (NYSE: ELV) receives 563 deferred stock units - Stock Titan
Elevance Health (ELV) director receives 563 deferred stock units as compensation - Stock Titan
Elevance Health (ELV) director receives 563 deferred stock units as compensation award - Stock Titan
Director at Elevance Health (NYSE: ELV) receives 563 deferred units - Stock Titan
Why UnitedHealthcare and other insurers are padding reserves - Modern Healthcare News
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):